Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Riemer

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Oncotarget|August 25, 2015
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistanceMarkus Morkel, Pamela Riemer, Hendrik Bläker, et al.
Current Opinion in Biotechnology|October 2, 2007
Road to precision: recombinase-based targeting technologies for genome engineeringDagmar Wirth, Leonor Gama-Norton, Pamela Riemer, et al.
International Journal of Cancer|February 21, 2012
Wnt and BMP signals control intestinal adenoma cell fatesAlexandra L Farrall, Pamela Riemer, Marc Leushacke, et al.
Nucleic Acids Research|September 22, 2017
Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylationNatascha Gödecke, Lisha Zha, Shawal Spencer, et al.
Cancers|February 11, 2023
Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant CharacteristicsRaik Otto, Katharina M Detjen, Pamela Riemer, et al.
The Journal of Cell Biology|April 27, 2017
Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoidsPamela Riemer, Mattias Rydenfelt, Matthias Marks, et al.
Urologic Oncology|June 10, 2019
Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancerGerald B Schulz, Tobias Grimm, Christine Sers, et al.
Plos Genetics|May 31, 2014
Ras-mediated deregulation of the circadian clock in cancerAngela Relógio, Philippe Thomas, Paula Medina-Pérez, et al.
Oncotarget|July 23, 2016
Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signalingYvonne Möller, Markus Morkel, Jens Schmid, et al.
Cancers|September 10, 2021
Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine NeoplasmsKatharina M Detjen, Raik Otto, Yvonne Giesecke, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Oncotarget|August 25, 2015
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistanceMarkus Morkel, Pamela Riemer, Hendrik Bläker, et al.
Current Opinion in Biotechnology|October 2, 2007
Road to precision: recombinase-based targeting technologies for genome engineeringDagmar Wirth, Leonor Gama-Norton, Pamela Riemer, et al.
International Journal of Cancer|February 21, 2012
Wnt and BMP signals control intestinal adenoma cell fatesAlexandra L Farrall, Pamela Riemer, Marc Leushacke, et al.
Nucleic Acids Research|September 22, 2017
Controlled re-activation of epigenetically silenced Tet promoter-driven transgene expression by targeted demethylationNatascha Gödecke, Lisha Zha, Shawal Spencer, et al.
Cancers|February 11, 2023
Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant CharacteristicsRaik Otto, Katharina M Detjen, Pamela Riemer, et al.
The Journal of Cell Biology|April 27, 2017
Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoidsPamela Riemer, Mattias Rydenfelt, Matthias Marks, et al.
Urologic Oncology|June 10, 2019
Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancerGerald B Schulz, Tobias Grimm, Christine Sers, et al.
Plos Genetics|May 31, 2014
Ras-mediated deregulation of the circadian clock in cancerAngela Relógio, Philippe Thomas, Paula Medina-Pérez, et al.
Oncotarget|July 23, 2016
Oncogenic Ras triggers hyperproliferation and impairs polarized colonic morphogenesis by autocrine ErbB3 signalingYvonne Möller, Markus Morkel, Jens Schmid, et al.
Cancers|September 10, 2021
Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine NeoplasmsKatharina M Detjen, Raik Otto, Yvonne Giesecke, et al.
Pageof 2